mRNA vaccination as a safe approach for specific protection from type I allergy. - Wikidata - awgldk - TriplyDB

mRNA vaccination as a safe approach for specific protection from type I allergy.

mRNA vaccination as a safe approach for specific protection from type I allergy.

http://www.wikidata.org/entity/Q37965722

about

Allergens are not pathogens: why immunization against allergy differs from vaccination against infectious diseases Recombinant messenger RNA technology and its application in cancer immunotherapy, transcript replacement therapies, pluripotent stem cell induction, and beyond Messenger RNA-based vaccines: progress, challenges, applications Potent immune responses in rhesus macaques induced by nonviral delivery of a self-amplifying RNA vaccine expressing HIV type 1 envelope with a cationic nanoemulsion.Potential of nanoparticles for allergen-specific immunotherapy - use of silica nanoparticles as vaccination platform.Nonviral delivery of self-amplifying RNA vaccines.Induction of Protective Immunity against Toxoplasma gondii in Mice by Nucleoside Triphosphate Hydrolase-II (NTPase-II) Self-amplifying RNA Vaccine Encapsulated in Lipid Nanoparticle (LNP).Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines.Development of nucleic acid vaccines: use of self-amplifying RNA in lipid nanoparticles.A development that may evolve into a revolution in medicine: mRNA as the basis for novel, nucleotide-based vaccines and drugs Self-replicating alphavirus RNA vaccines.mRNA transcript therapy.RNA Vaccination Therapy: Advances in an Emerging Field.Prophylactic mRNA Vaccination against Allergy Confers Long-Term Memory Responses and Persistent Protection in Mice.What is the antiallergic potential of DNA vaccination?The messenger's great message for vaccination.Generation and Evaluation of Prophylactic mRNA Vaccines Against Allergy.

P2860

Q26828969-4AD32095-AE77-4306-B3FD-E89058BAD32A Q26861563-27C922C6-3AE9-4696-ACFB-B3B13C3F656A Q27012738-F0296A95-6A67-4600-8A58-CF3BFE7F0589 Q35558828-6F582A2E-F017-471C-86FF-06D04DCBC420 Q36056484-1307B501-CFE9-4787-A020-09EE3FDC97BF Q36221799-6330AB6A-ED27-4BA1-8D53-A0B6342DA64B Q37737615-9E10F346-3BA7-4E43-A791-78AF502DD66F Q38199151-4814F3B9-1858-4DCC-B8A7-475BB95341BE Q38205757-D46A6E5B-31B2-459A-898B-5BA846FC2BD6 Q38206520-E73323C3-632A-4221-8C73-6EE2E73CDD91 Q38255634-8B1DC04E-BA21-44FE-97C7-30490409FA55 Q38264088-329B72A0-2694-44AD-91F7-77F916F2E62A Q38891036-32F0E068-C02D-4978-8DAB-44BFA97332F8 Q43194033-43A93134-5B6B-4D0D-9A12-9F2B74312765 Q48027406-3EE6DDD7-4CA2-4BF1-89D0-14C0F9364E43 Q51068251-1187507C-4434-4090-9B62-724C62D1DF1D Q51253941-EA82765C-C015-4AB3-A506-A9E8036B4214

P2860

mRNA vaccination as a safe approach for specific protection from type I allergy.

http://www.wikidata.org/entity/Q37965722

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

mRNA vaccination as a safe approach for specific protection from type I allergy.

@en

mRNA vaccination as a safe approach for specific protection from type I allergy.

@nl

type

label

mRNA vaccination as a safe approach for specific protection from type I allergy.

@en

mRNA vaccination as a safe approach for specific protection from type I allergy.

@nl

prefLabel

mRNA vaccination as a safe approach for specific protection from type I allergy.

@en

mRNA vaccination as a safe approach for specific protection from type I allergy.

@nl

P1433

Q37965722-8C55860B-585C-4ABF-8BAB-86131A33A441

P1476

Q37965722-B23F4E43-F3E4-4DC9-B297-1EF780743F61

P2093

Q37965722-07A7A339-B7D8-4CBD-8683-F68249E04AD3

Q37965722-7953FCE8-9BBE-4601-841A-A65EEC37E815

Q37965722-7BE07CB5-366A-4308-AB05-3558AD9E1D57

Q37965722-A148E1E4-4C31-44AE-8244-AFC8ADCD0B89

P2860

Q37965722-0EC88393-08B1-4F9D-A9D2-5D631ADCE68A

Q37965722-0FCAB07C-DD0E-44D0-AFFC-80775811039C

Q37965722-0FD79574-7A20-45B2-AB7A-279E766AD51F

Q37965722-10043F87-2B04-4847-99D0-3E7159F05A96

Q37965722-11405260-F885-42CD-80FA-866B2CBB0345

Q37965722-146E5A43-A845-49E5-B257-CB0D08D514CF

Q37965722-1485D92D-80F0-4536-9CA5-A564192A03DC

Q37965722-15CA693B-660B-42A4-A6C6-40A00499897F

Q37965722-1ADA308B-743A-41ED-8B20-CFAF91FF7D66

Q37965722-1C287A36-0852-41BD-8B1B-12613C50219B

P304

Q37965722-DCE95713-1B95-47DC-96AD-A8DBB318F80B

P31

Q37965722-68368556-F6E4-44AF-B09F-7DF64F01603F

P356

Q37965722-839D0F77-EE2C-4EE4-877F-9627008589E5

P433

Q37965722-00DD2BB6-3D42-4CD3-AC47-DD2797AC4DFE

P478

Q37965722-1282FE8B-45FF-43BA-93D1-C84CE542E441

P50

Q37965722-4834E529-ADFE-4AAA-A8E6-7C688033DB3C

P577

Q37965722-A5D9BA9F-96FB-4ABD-A9DB-22070388C702

P698

Q37965722-517F7C93-38DC-4D74-8CE6-7022EB33E4CE

P356

P1433

Expert Review of Vaccines

P1476

mRNA vaccination as a safe approach for specific protection from type I allergy

@en

P2093

Elisabeth Roesler

http://www.w3.org/2001/XMLSchema#string

Esther Weinberger

http://www.w3.org/2001/XMLSchema#string

Josef Thalhamer

http://www.w3.org/2001/XMLSchema#string

Sandra Scheiblhofer

http://www.w3.org/2001/XMLSchema#string

P2860

Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8

Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization

UTRdb and UTRsite (RELEASE 2010): a collection of sequences and regulatory motifs of the untranslated regions of eukaryotic mRNAs

Humoral and cellular immune response to RNA immunization with flavivirus replicons derived from tick-borne encephalitis virus.

The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses

Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA

Environmental exposure to endotoxin and its relation to asthma in school-age children

Uptake and trafficking of DNA in keratinocytes: evidence for DNA-binding proteins.

Modulation of allergic immune responses by mucosal application of recombinant lactic acid bacteria producing the major birch pollen allergen Bet v 1.

Endocytosis of DNA-Hsp65 alters the pH of the late endosome/lysosome and interferes with antigen presentation.

P304

55-67

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ERV.11.168

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22149709

http://www.w3.org/2001/XMLSchema#string